Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 3.10.2024Zentiva, k.s. (ZNT-1)84762Rosucard 20 mg filmom obalené tablety (tbl flm 90x20 mg (blis.OPA/Al/PVC//Al))3.10.2024R
 3.10.2024Zentiva, k.s. (ZNT-1)86656NEUROL 1,0 (tbl 30x1,0 mg (blis. PVC/Al))7.10.2024R
 3.10.2024Zentiva, k.s. (ZNT-1)91788NEUROL 0,25 (tbl 30x0,25 mg (blis. PVC/PVDC/Al))7.10.2024R
 3.10.2024B.Braun Melsungen AG (BME)10440Gelaspan 4% (sol inf 20x500 ml (vak plast.-Ecobag))3.10.2024R
 2.10.2024Bausch Health Ireland Limited (BAU-1)51897Relistor 12 mg/0,6 ml injekčný roztok (sol inj 7x0,6 ml/12 mg (7 liek.inj.skl.+7 steril.inj.striek.+14 alkoh.tamp.))15.10.2024R
 2.10.2024Exeltis Slovakia s.r.o. (EET)6835EKelzy 2 mg/0,02 mg tablety s predĺženým uvoľňovaním (tbl plg 1x28x2 mg/0,02 mg (blis. PVC/PE/PVDC/Al))2.9.2024U
 2.10.2024Fresenius Kabi s.r.o. (FRK-CZ-3)3238AZoledronic Acid Fresenius Kabi 4 mg/5 ml infúzny koncentrát (con inf 1x5 ml/4 mg (liek.inj.plast.))2.10.2024R
 2.10.2024B.Braun Melsungen AG (BME)76566Metronidazol B. Braun 5 mg/ml (sol inf 20x100 ml/500 mg (fľ. PE))2.10.2024R
 2.10.2024Dr. Gerhard Mann Chem.-pharm. Fabrik GmbH (MNN)92977CARTEOL LP 20 mg/ml (int plg 3x3 ml (fľ.PE))2.10.2024O
 2.10.2024Astellas Pharma Europe B.V. (ASL-2)8496DEvrenzo 50 mg filmom obalené tablety (tbl flm 12x1x50 mg (blis.PVC/Al - jednotk.bal.))2.10.2024R
 1.10.2024N.V. Organon (ORG-NL)86057NASONEX (aer nau 3x18 g/140 dávok (fľ.HDPE s dávkovačom))24.9.2024O
 1.10.2024IMUNA PHARM, a.s. (IMA)3462CChlorid sodný 0,9 % IMUNA ENVIBAG (sol inf 1x250 ml (vak PP-infúzny s inf.a inj.portom))1.10.2024R
 1.10.2024IMUNA PHARM, a.s. (IMA)3463CChlorid sodný 0,9 % IMUNA ENVIBAG (sol inf 1x500 ml (vak PP-infúzny s inf.a inj.portom))1.10.2024R
 1.10.2024IMUNA PHARM, a.s. (IMA)3464CChlorid sodný 0,9 % IMUNA ENVIBAG (sol inf 1x1000 ml (vak PP-infúzny s inf.a inj.portom))1.10.2024R
 1.10.2024IMUNA PHARM, a.s. (IMA)3901CINFUSIO GLUCOSI 10 IMUNA (sol inf 1x250 ml (vak plast.PP))1.10.2024R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)